Prostaglandins Leukot Essent Fatty Acids. 1995 May;52(5):293-7.

Essential fatty acids are antagonists of the leukotriene B4 receptor.

Yagaloff KA, Franco L, Simko B, Burghardt B.

Source

Department of Metabolic Disease Research, Hoffmann-La Roche, Nutley, NJ 07110, USA.

Abstract

A series of essential fatty acids and fatty acid derivatives were evaluated for their ability to inhibit [3H] leukotriene B4 (LTB4) binding to pig neutrophil membranes. The fatty acids varied in chain length, extent of unsaturation, position of unsaturation, and isomerization. Generally, fatty acids with two or more unsaturated sites and chain lengths of 18-22 were potent inhibitors of [3H]LTB4 binding; both n-3 and n-6 fatty acids were inhibitory. The most potent compounds tested were homogammalinolenic acid and ricinelaidic acid which gave Ki values of 1 microM and 2 microM in the binding assay. Ricinelaidic acid was also tested for its ability to inhibit LTB4-mediated chemotaxis (IC50 = 10 microM) and LTB4-induced calcium fluxes (IC50 = 7 microM) in isolated human neutrophils. Ricinelaidic acid did not show agonist activity in these assays. In an in vivo model of LTB4-induced bronchoconstriction, ricinelaidic acid and homogammalinolenic acid gave 46% and 53% inhibition, respectively, at a 1 mg/kg i.v. dose. These results indicate that essential fatty acids are LTB4 receptor antagonists, which may account in part for their reported anti-inflammatory activities.

PMID:: 7630916; [PubMed - indexed for MEDLINE]

LinkOut - more resources

Full Text Sources

Swets Information Services

Molecular Biology Databases

Supplemental Content

Related citations

Pharmacologic actions of the second-generation leukotriene B4 receptor antagonist LY293111: in vitro studies. [J Pharmacol Exp Ther. 1999]
Pharmacologic actions of the second-generation leukotriene B4 receptor antagonist LY293111: in vitro studies.
Jackson WT, Froelich LL, Boyd RJ, Schrementi JP, Saussy DL Jr, Schultz RM, Sawyer JS, Sofia MJ, Herron DK, Goodson T Jr, et al. J Pharmacol Exp Ther. 1999 Jan; 288(1):286-94.
The leukotriene B4 receptor agonist/antagonist activities of SC-45694 in human neutrophils. [J Pharmacol Exp Ther. 1994]
The leukotriene B4 receptor agonist/antagonist activities of SC-45694 in human neutrophils.
Tsai BS, Keith RH, Villani-Price D, Haack RA, Djuric SW. J Pharmacol Exp Ther. 1994 Mar; 268(3):1493-8.
In vitro and in vivo pharmacological characterization of SB 201993, an eicosanoid-like LTB4 receptor antagonist with anti-inflammatory activity. [Prostaglandins Leukot Essent Fatty Acids. 1...]
In vitro and in vivo pharmacological characterization of SB 201993, an eicosanoid-like LTB4 receptor antagonist with anti-inflammatory activity.
Sarau HM, Foley JJ, Schmidt DB, Martin LD, Webb EF, Tzimas MN, Breton JJ, Chabot-Fletcher M, Underwood DC, Hay DW, et al. Prostaglandins Leukot Essent Fatty Acids. 1999 Jul; 61(1):55-64.
Review Modulation of pro-inflammatory cytokine biology by unsaturated fatty acids. [Z Ernahrungswiss. 1998]
Review Modulation of pro-inflammatory cytokine biology by unsaturated fatty acids.
Grimble RF, Tappia PS. Z Ernahrungswiss. 1998; 37 Suppl 1:57-65.
Review Leukotriene B4: an inflammatory mediator with vascular actions in vivo. [Agents Actions Suppl. 1982]
Review Leukotriene B4: an inflammatory mediator with vascular actions in vivo.
Bray MA. Agents Actions Suppl. 1982; 11:51-61.

See reviews... See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Essential fatty acids are antagonists of the leukotriene B4 receptor.
Essential fatty acids are antagonists of the leukotriene B4 receptor.
Prostaglandins Leukot Essent Fatty Acids. 1995 May ;52(5):293-7.

PubMed
Risk factors for stillbirth in developing countries: a systematic review of the ...
Risk factors for stillbirth in developing countries: a systematic review of the literature.
Sex Transm Dis. 2007 Jul ;34(7 Suppl):S11-21.

PubMed
Conservative treatment of acute and chronic nonspecific low back pain. A systema...
Conservative treatment of acute and chronic nonspecific low back pain. A systematic review of randomized controlled trials of the most common interventions.
Spine (Phila Pa 1976). 1997 Sep 15 ;22(18):2128-56.

PubMed
A high-resolution anatomical ontology of the developing murine genitourinary tra...
A high-resolution anatomical ontology of the developing murine genitourinary tract.
Gene Expr Patterns. 2007 Jun ;7(6):680-99. Epub 2007 Mar 23 .

PubMed
Use of dual section mRNA in situ hybridisation/immunohistochemistry to clarify g...
Use of dual section mRNA in situ hybridisation/immunohistochemistry to clarify gene expression patterns during the early stages of nephron development in the embryo and in the mature nephron of the adult mouse kidney.
Histochem Cell Biol. 2008 Nov ;130(5):927-42. Epub 2008 Jul 11 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to:

Essential fatty acids are antagonists of the leukotriene B4 receptor.

Source

Abstract

MeSH Terms, Substances

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Molecular Biology Databases

Supplemental Content

Related citations

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information